Resources

PATH and partners issue a statement responding to the president’s Budget Request for FY 2019, calling on Congress to sustain and protect the International Affairs Budget at a minimum of current FY 2017 levels.

PATH’s global community of donors and partners stepped up to support health equity through the Reach Campaign, our first major fundraising initiative. This report shares the final campaign results, including what PATH donors have made possible through their support.

This two-page fact sheet provides an overview of evidence and recommendations supporting the safety of the live attenuated CD-JEV Japanese encephalitis vaccine.

Blow-fill-seal (BFS) technologies use a polymer material to form the container. BFS is widely used for packaging of single-dose pharmaceuticals, but has yet to be introduced for vaccines. The BFS manufacturing process can accommodate the filling of multiple containers into a single strip with a flexible detachment point, allowing for the easy separation of each unit-dose container at the point of delivery.

This Vaccine and Pharmaceutical Technologies documents answers frequently asked questions regarding one type of freeze-preventive vaccine carrier. It includes why vaccine freezing is a problem, the benefits of freeze-preventive carriers, and the next steps for the technology.